Abstract
We read with interest the report by Siguret et al1 on the initiation of anticoagulation therapy in elderly patients. This issue is a matter of significant importance in clinical medicine, and their article has the potential to impact our practice. However, we have a few comments that we would like to make.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
